Tam P E, Messner R P
Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, USA.
J Virol. 1999 Dec;73(12):10113-21. doi: 10.1128/JVI.73.12.10113-10121.1999.
Enterovirus infection and persistence have been implicated in the pathogenesis of certain chronic muscle diseases. In vitro studies suggest that persistent enteroviruses mutate, evolving into forms that are less lytic and display altered tropism, but it is less clear whether these mechanisms operate in vivo. In this study, persistent coxsackievirus RNA from the muscle of mice afflicted with chronic inflammatory myopathy (CIM) was characterized and compared with RNA from a virus that had established a persistent infection of G8 mouse myoblasts for 30 passages in vitro. Competitive strand-specific reverse transcription-PCR and susceptibility to RNase I treatment revealed that plus- and minus-strand viral RNAs were present at nearly equivalent levels in muscle and that they persisted in a double-stranded conformation. All regions of the viral genome persisted and were amplified as a series of seven overlapping fragments. Restriction endonuclease fingerprinting coupled with sequencing indicated that there was no evolution of the viral genome associated with its persistence in muscle. This contrasted with the productive persistent infection that was established in myoblast cultures, where plus-strand RNA predominated and persistent virus developed distinct mutations. In vitro persistence proceeded by a carrier culture mechanism and was completely dependent on production of infectious virus, since persistent viral RNA was not detected in cultures subjected to antibody-mediated curing. These experiments demonstrate that persistence of coxsackievirus RNA in muscle is not facilitated by distinct genetic changes in the virus that give rise to replication-defective forms but occurs primarily through production of stable double-stranded RNA that is produced as the acute viral infection resolves. The data suggest a mechanism for coxsackievirus persistence in myofibers and perhaps other nondividing cells whereby cells that survive infection could harbor persistent viral RNA for extended times without producing detectable levels of infectious virus.
肠道病毒感染及持续存在与某些慢性肌肉疾病的发病机制有关。体外研究表明,持续存在的肠道病毒会发生突变,演变成裂解性较弱且嗜性改变的形式,但这些机制在体内是否起作用尚不清楚。在本研究中,对患有慢性炎症性肌病(CIM)的小鼠肌肉中持续存在的柯萨奇病毒RNA进行了表征,并与在体外连续传代30次建立了对G8小鼠成肌细胞持续感染的病毒的RNA进行了比较。竞争性链特异性逆转录PCR和对RNase I处理的敏感性表明,正负链病毒RNA在肌肉中的含量几乎相等,并且它们以双链构象持续存在。病毒基因组的所有区域都持续存在,并作为一系列七个重叠片段进行扩增。限制性内切酶指纹图谱结合测序表明,病毒基因组在肌肉中的持续存在与其进化无关。这与在成肌细胞培养物中建立的增殖性持续感染形成对比,在成肌细胞培养物中,正链RNA占主导地位,持续存在的病毒会发生明显的突变。体外持续存在是通过载体培养机制进行的,并且完全依赖于感染性病毒的产生,因为在经过抗体介导清除的培养物中未检测到持续存在的病毒RNA。这些实验表明,柯萨奇病毒RNA在肌肉中的持续存在并非由产生复制缺陷形式的病毒的独特基因变化所促进,而是主要通过在急性病毒感染消退时产生的稳定双链RNA来实现。数据表明了柯萨奇病毒在肌纤维以及可能在其他非分裂细胞中持续存在的一种机制,即感染后存活的细胞可以长时间携带持续存在的病毒RNA而不产生可检测水平的感染性病毒。